Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126859371 | 12685937 | 1 | I | 201511 | 20160115 | 20160825 | 20160825 | PER | US-FRI-1000082227 | FOREST | 74.77 | YR | M | Y | 72.57000 | KG | 20160825 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126859371 | 12685937 | 1 | PS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 5MG | N | 21323 | 5 | MG | TABLET | QD | |||||
| 126859371 | 12685937 | 2 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10MG | N | 21323 | 10 | MG | TABLET | QD | |||||
| 126859371 | 12685937 | 3 | SS | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 5MG | N | 21323 | 5 | MG | TABLET | QD | |||||
| 126859371 | 12685937 | 4 | SS | FINASTERIDE. | FINASTERIDE | 1 | Oral | 0 | 5 | MG | |||||||||
| 126859371 | 12685937 | 5 | SS | SPIRONOLACTONE. | SPIRONOLACTONE | 1 | Oral | 25MG | N | 0 | 25 | MG | TABLET | QD | |||||
| 126859371 | 12685937 | 6 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
| 126859371 | 12685937 | 7 | C | LISINOPRIL. | LISINOPRIL | 1 | 5MG | 0 | 2.5 | MG | Q12H | ||||||||
| 126859371 | 12685937 | 8 | C | IMDUR | ISOSORBIDE MONONITRATE | 1 | Oral | 30MG | 0 | 30 | MG | TABLET | QD | ||||||
| 126859371 | 12685937 | 9 | C | LASIX | FUROSEMIDE | 1 | Oral | 80MG | 0 | 20 | MG | TABLET | QID | ||||||
| 126859371 | 12685937 | 10 | C | METOPROLOL. | METOPROLOL | 1 | Oral | 100MG | 0 | 100 | MG | TABLET | QD | ||||||
| 126859371 | 12685937 | 11 | C | DIGOXIN. | DIGOXIN | 1 | Oral | 125MCG | 0 | 125 | UG | TABLET | QD | ||||||
| 126859371 | 12685937 | 12 | C | LORATADINE. | LORATADINE | 1 | Oral | 0 | 10 | MG | |||||||||
| 126859371 | 12685937 | 13 | C | SIMVASTATIN. | SIMVASTATIN | 1 | Oral | 20MG | 0 | 20 | MG | TABLET | QD | ||||||
| 126859371 | 12685937 | 14 | C | TAMSULOSIN | TAMSULOSIN | 1 | Oral | 0.4MG | 0 | .4 | MG | CAPSULE | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126859371 | 12685937 | 1 | Depression |
| 126859371 | 12685937 | 2 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126859371 | 12685937 | Gynaecomastia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126859371 | 12685937 | 1 | 20151125 | 20151129 | 0 | |
| 126859371 | 12685937 | 2 | 20151130 | 20160115 | 0 | |
| 126859371 | 12685937 | 3 | 20160116 | 0 | ||
| 126859371 | 12685937 | 5 | 20160119 | 0 |